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OBJECTIVE—The contribution of mitochondrial dysfunction to
skeletal muscle insulin resistance remains elusive. Comparative
proteomics are being applied to generate new hypotheses in
human biology and were applied here to isolated mitochondria to
identify novel changes in mitochondrial protein abundance
present in insulin-resistant muscle.
RESEARCH DESIGN AND METHODS—Mitochondria were
isolated from vastus lateralis muscle from lean and insulin-sensitive
individuals and from obese and insulin-resistant individuals who
were otherwise healthy. Respiration and reactive oxygen species
(ROS) production rates were measured in vitro. Relative abun-
dances of proteins detected by mass spectrometry were determined
using a normalized spectral abundance factor method.
RESULTS—NADH- and FADH2-linked maximal respiration rates
were similar between lean and obese individuals. Rates of pyruvate
and palmitoyl-DL-carnitine (both including malate) ROS production
were significantly higher in obesity. Mitochondria from obese
individuals maintained higher (more negative) extramitochondrial
ATP free energy at low metabolic flux, suggesting that stronger
mitochondrial thermodynamic driving forces may underlie the
higher ROS production. Tandem mass spectrometry identified pro-
tein abundance differences per mitochondrial mass in insulin resis-
tance, including lower abundance of complex I subunits and
enzymes involved in the oxidation of branched-chain amino acids
(BCAA) and fatty acids (e.g., carnitine palmitoyltransferase 1B).
CONCLUSIONS—We provide data suggesting normal oxidative
capacity of mitochondria in insulin-resistant skeletal muscle in
parallel with high rates of ROS production. Furthermore, we
show specific abundance differences in proteins involved in fat
and BCAA oxidation that might contribute to the accumulation of
lipid and BCAA frequently associated with the pathogenesis of
insulin resistance. Diabetes 59:2444–2452, 2010
Defining the role of mitochondrial dysfunctionin the pathogenesis of skeletal muscle insulinresistance has been challenging. If mitochon-dria were less able to oxidize fatty acids,
intramyocellular triacylglycerol and its metabolites,
such as long-chain fatty acyl-CoAs, would rise, leading
to impaired insulin signaling and insulin resistance (1).
Mitochondrial mass is consistently 14–38% lower in
muscle in obesity and type 2 diabetes (2–5). In vivo
studies, using magnetic resonance spectroscopy, con-
cluded that basal and insulin-stimulated ATP synthesis
rates were lower in insulin-resistant offspring of pa-
tients with type 2 diabetes (6,7). Although these data
suggest intrinsic mitochondrial impairment, it may be
that differences in mitochondrial content and cellular
ATP demand underlie these observations.
Measurements on isolated mitochondria show that
maximal respiration is lower in muscle from type 2
diabetics (8). Studies using saponin-permeabilized iso-
lated human skeletal muscle (SM) fibers reported nor-
mal (9) or impaired (10) respiration in type 2 diabetic
subjects. Nair et al., in 2009, showed dissociation be-
tween insulin sensitivity and mitochondrial ATP synthe-
sis rates while demonstrating an effect of age on
isolated mitochondrial activity (11). Given the diversity
of these results, the contribution of mitochondrial oxi-
dative capacity to insulin resistance is poorly defined.
Besides an intrinsic impairment in oxidative capacity,
increased oxidative stress could produce insulin resis-
tance (12). The superoxide anion (O2) is derived from
several cellular sources, but the main contributor in SM
may be electron leakage from mitochondria (13). At rest,
0.1–0.2% of consumed oxygen is converted to reactive
oxygen species (ROS) (14). Insulin-resistant animal mod-
els have higher levels of superoxide production (15), and
healthy individuals fed a high-fat diet had increased ROS
generation in permeabilized muscle fibers without a
change in mitochondrial respiration (16).
This study was undertaken to identify abnormalities in
mitochondria isolated from insulin-resistant muscle by
assessing mitochondrial bioenergetics and ROS produc-
tion rates combined with proteomic assessment of abun-
dance of mitochondrial proteins.
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RESEARCH DESIGN AND METHODS
Subjects. The purpose, nature and potential risks of the study were explained
to the participants, and written consent was obtained. The protocol was
approved by the institutional review board of Arizona State University.
Additional information is provided in an online appendix (http://diabetes.
diabetesjournals.org/cgi/content/full/db10-0174/DC1).
Muscle biopsy and hyperinsulinemic-euglycemic clamp. Participants un-
derwent a euglycemic-hyperinsulinemic clamp with basal muscle biopsies,
regarding which the online appendix provides additional information.
Myosin heavy-chain isoform distribution. Myosin heavy-chain (MHC)
isoform composition was determined as previously described (17). MHC I, IIx,
and IIa protein bands were visualized using Coomasie stain and quantified
using densitometry.
Small scale isolation of mitochondria. The online appendix provides
information regarding the small-scale isolation of mitochondria.
Mitochondrial energetics. Oxygen uptake by isolated mitochondria was
measured using a DW1 Electrode Chamber (Hansatech Instruments, Norfolk,
U.K.) in 250 l respiration medium containing (in millimolar): 100 KCl, 50
3-[N-morpholino] propanesulfonic acid, 10 K.PO4, 20 glucose, 10 MgCl2, 1
EGTA, and 0.2% BSA, pH 7.0, at 37°C. Indexes of mitochondrial function were
assessed using the following:: 1 mmol/l pyruvate, 10 mmol/l glutamate, 10
mol/l palmitoyl-DL-carnitine (PC), and 5 mmol/l succinate. All substrates
included 1 mmol/l malate to prime the citrate cycle. Mitochondria (10–50 g)
and substrates were added to respiration medium, and maximal (state 3) O2
consumption rate (JO2) was stimulated with 125 nmol ADP (0.5 mmol/l).
Complete phosphorylation of this ADP bolus elicited transition to resting JO2
(state 4), which allowed calculation of the ADP-to-O ratio and the state
3–to–state 4 ratio (respiratory control ratio).
Citrate synthase activity. Citrate synthase activity was measured using the
method of Srere (18). The online appendix provides further information.
Sensitivity of mitochondria to metabolic control signals. The sensitivity
of mitochondrial respiration to kinetic and thermodynamic control signals
(free ADP and ATP free energy, respectively) was assessed using the “creatine
kinase energy clamp” of Messer et al. (19). Mitochondria (40–60 g protein)
were added to respiration medium containing 1.22 mmol/l phosphocreatine
(PCr), 5.0 mmol/l creatine (Cr), and 5.0 mmol/l ATP. Creatine kinase was
added in excess (30 units creatine kinase; Sigma Chemical, St. Louis, MO) to
maintain thermodynamic equilibrium. Free [ADP] ([ADP]f) was calculated
using the equilibrium constant of the creatine kinase reaction (KCK), assumed
to be 150 (20):
ADP f  ATPCr/PCrKCK
The [ADP]f with the known phosphate ([Pi]) of the medium provided the
extramitochondrial free energy of ATP (GATP): GATP 	 RTLn(
/KATP),
where R is the gas constant, T is degrees Kelvin, 
 is the mass action ratio of
the ATP hydrolysis reaction ([ADP]f[Pi]/[ATP]), and KATP is the equilibrium
constant of ATP hydrolysis (225,000, based on the study of Teague and
Dobson [20]).
Stepwise additions of PCr established progressively lower [ADP]f and
higher (more negative) GATP, suppressing mitochondrial respiration (supple-
mental Fig. 1). Eadie-Hofstee analysis of the [ADP]f:JO2 relation yielded the
KMADP for respiration. Plots of GATP:JO2 were near linear (thermodynamic
force-flow relation) and were extrapolated through the abscissa to calculate
the theoretical GATP at zero respiration (static head energy) (Fig. 3A).
ROS measurement. Substrates (see MITOCHONDRIAL ENERGETICS for concentra-
tions of substrates [10 mol/l rotenone and 1 g/l oligomycin]) were added
to respiration medium. Horseradish peroxidase (20 mU) and 10-Acetyl-3,7-
dihydroxyphenoxazine (17 ng/l) were added to a 96-well plate. ROS produc-
tion was initiated by the addition of 10 g mitochondrial protein. Optical
density was measured every 5 min for 30 min (ex: 550 and em: 590 nm). Due
to limited material, 10 g rat mitochondria were added to the H2O2 standard
curve to correct for signal quenching by mitochondria.
Mass spectrometry sample preparation. Forty micrograms of mitochon-
drial protein were separated by one-dimensional SDS polyacrylamide gel
(12%). Proteins were visualized with Coomassie blue (Sigma Chemical, St.
Louis, MO). Gel lanes (supplemental Fig. 2) were cut into 20 slices. Each slice
was destained, dehydrated, and digested with trypsin as previously described
in detail (21). The volume of the extracted peptide solution was reduced to 5
l by vacuum centrifugation, and 20 l of 0.1% trifluoroacetic acid/1% formic
acid/2% acetonitrile was added.
Mass spectrometry. High-performance liquid chromatography–electrospray
ionization–tandem mass spectrometry was performed on a hybrid linear ion
trap–Fourier Transform ion cyclotron resonance mass spectrometer (LTQ FT;
Thermo Fisher; San Jose, CA) fitted with a PicoView nanospray source (New
Objective, Woburn, MA) (refer to Supplemental Information).
Data analysis and bioinformatics. Assignment of individual proteins was
completed using Mascot (version 2.2; Matrix Science, London, U.K.) and
Scaffold (version 02_00_06; Proteome Software, Portland, OR) as previously
described (21) (refer to Supplemental Information).
Normalized spectral abundance factor calculations and immunoblot-
ting. Normalized spectral abundance factors (NSAFs) were calculated for
every protein detected in each isolated mitochondria sample as previously
described by Hwang et al. (22), who confirmed that this methodology can be
applied to complex protein mixtures in a reproducible fashion. In addition,
loading 30–120 g protein lysate generates similar NSAF values (22). Briefly,
NSAF values were log2 transformed to yield a Gaussian distribution. For every
protein, the average lean log2 NSAF values were subtracted from all log2 NSAF
values (both lean and obese groups), resulting in a log2-fold change for the
obese group relative to the lean group. The online appendix provides
information regarding immunoblotting.
RESULTS
Metabolic and skeletal muscle characteristics. Lean
and obese participants were matched for age, sex, and
aerobic capacity (VO2max) (Table 1). Obese individuals had
higher BMI (P  0.01), fasting plasma insulin (P  0.01),
A1C (P  0.01), and fasting plasma glucose (P  0.05).
Insulin-stimulated glucose disposal was lower in the obese
group (7.9  0.6 vs. 3.7  0.3 mg  kg1  min1; P  0.01);
suppression of endogeneous glucose output was complete
in both groups (0.1  0.1 vs. 0.0  0.1 mg  kg1  min1).
Obese participants had a higher proportion of myosin
heavy-chain IIx (MYHI) (P  0.05). No differences in MHC
TABLE 1
Clinical, metabolic, and skeletal muscle characteristics
Lean Obese
N 20 14
Male/female 11/9 7/7
Age (years) 38 3 38  4
BMI (kg/m2) 25  1 36  1*
Weight (kg) 77.6 3.6 103.1 4.2
Fat mass (kg) 20.4 2.8 37.4 2.5*
Plasma glucose (mg/dl) 86 2 93  2†
Serum insulin (pmol/l) 30 6 90  12*
A1C (%) 5.4 0 5.7  0.1*
HDL cholesterol (mmol/l) 51 3 46  2
LDL cholesterol (mmol/l) 109 9 113 8
Plasma triglycerides (mmol/l) 85 8 126  21†
OGTT (2-h glycemia) 105 6 135  8*
Rd basal (mg  kg1  min1) 2.1  0.1 1.8  0.1*
Rd clamp (mg  kg1  min1) 7.9  0.6 3.7 0.3*
HGP clamp (mg  kg1 
min1) 0.1  0.1 0.0 0.1
Pulse (bpm) 67 2 71  2
Systolic/diastolic blood
pressure (mmHg) 124 5/82 3 130 3/87 2
Vo2max (ml  min
1  kg1) 31.5 1.9 25.9 1.8
Vo2max (ml  min
1  kg
FFM1) 42.9 2.4 38.8 2.0
% MHC I 31 4 24  3
% MHC IIx 21 2 31  4*
% MHC IIa 48 6 45  6
Isolated mitochondrial protein
(g/l)‡ 6.5 0.3 5.4 0.2*
Isolated citrate synthase
activity (mol  min1  g
wet weight1) 8.2  0.6 6.0  0.2*
Mitochondria recovery (%) 66 3 64  3
Data are presented as means  SE. Student’s t test was performed.
*P  0.01 and †P  0.05 vs. lean participants. ‡Mitochondria pellets
were resuspended in 100 l of mannitol-sucrose buffer. HGP, hepatic
glucose production.
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IIa (MYH2) or I (MYH7) were observed. Total mitochon-
drial protein and citrate synthase activity isolated per
muscle wet weight were lower in obese individuals (P 
0.01), although the proportion of mitochondria recovered
in both lean and obese groups was similar (65%).
In vitro mitochondrial oxidative capacity. ADP-to-O
and respiratory control ratios were within previously
published ranges for isolated mitochondria from human
muscle and did not differ between groups (Table 2).
Maximal and resting respiration in response to NADH-
linked (pyruvate, malate, and glutamate) and FADH2-
linked (succinate) substrates did not differ between the
groups (Fig. 1A and B). PC oxidation also was similar
between both groups.
ROS production. Rates of ROS production were mea-
sured in the presence of oligomycin in a situation where
the ETC complexes were highly reduced by the influx of
electrons provided by NADH (pyruvate and PC) and
FADH2 (PC). Theoretical sites of ROS production are
shown in Fig. 2A. With pyruvate and PC (both including
malate), insulin-resistant muscle mitochondria produced
ROS at higher rates than did insulin-sensitive muscle (Fig.
2B). Rotenone addition to inhibit passage of electrons
from complex I to ubiquinone typically results in increased
ROS production (23). However, rotenone raised ROS
production only in the mitochondria from insulin-sensitive
individuals.
Mitochondrial sensitivity to metabolic control sig-
nals. Steady-state respiration rates spanning the aerobic
range were established by experimentally manipulating
extramitochondrial energy phosphate levels (ADP) with
the creatine kinase energy clamp. Supplemental Fig. 1
shows a typical experiment using stepwise addition of
phosphocreatine. Eadie-Hofstee plots of JO2 vs. JO2/[ADP]
yielded similar values for the KMADP for respiration (35 
2 mol/l for lean vs. 31  4 for obese; P 	 0.33). Figure 3A
shows a typical relationship between GATP and oxygen
consumption. The GATP:JO2 (force flow) relation extrap-
olated through the abscissa indicated a higher (more
negative) static head GATP in insulin-resistant muscle
mitochondria (P 	 0.003) (Fig. 3B). The slope of the
force-flow relationship in the lean group showed a trend to
be higher than that in the obese group (95.4  7.1 vs.
75.4  8.8 nmol O2  min
1  kcal1  mol1 (P  0.10)
(supplemental Fig. 3).
Differences in mitochondrial protein abundance. The
number of unique proteins assigned per mitochondrial
isolate was similar between the groups (lean 425  19 vs.
obese 422  29 proteins; P 	 n.s.), as were the number of
total known mitochondrial proteins (lean 248  8 vs.
obese 236  13 mitochondrial proteins; P 	 n.s.). A
composite list assigned 691 unique proteins. In addition,
the total spectra generated solely by known mitochondrial
proteins did not differ between groups (lean 19,683 1,421
vs. obese 18889  1,238; P 	 n.s.). Approximately 60% of
total spectra were assigned to known mitochondrial
proteins.
Electron chain complexes. Table 3 depicts the number
of assigned subunits in at least half of all participants.
Complex II (succinate dehydrogenase) and III (ubiqui-
none: cytochrome c reductase) subunits were present in
equal numbers per mitochondrial mass in insulin-sensitive
and insulin-resistant muscle. A number of complex I
subunits (P  0.05: NDUFC2, NDUFA8, NDUFA11,
NDUFS2, and NDUFB8; P 0.10: NDUFS5, NDUFB3, and
MTND1) were observed to be lower in abundance in
mitochondria from the obese group. The iron-sulfur clus-
ter scaffold protein (NFU1) was also lower in the obese
group (P  0.05). Only one subunit from complex IV was
significantly decreased in obesity: COX5B (Table 4).
TABLE 2
Respiratory control and ADP-to-O ratios
Lean Obese
RCR
P  M 20.5  1.8 17.4 1.3
PC  M 9.1 1.6 11.4 1.7
P  M  GLU 12.9 2.4 14.1 1.4
GLU  MAL 16.1 1.4 13.7 2.3
P  M  GLU  SUCC 10.0 0.6 10.7 1.2
ADP/O
P  M 2.30  0.03 2.26 0.05
PC  M 1.94 0.05 1.88 0.06
P  M GLU 2.14 0.06 2.03 0.06
GLU  MAL 2.12 0.08 2.02 0.07
P  M  GLU  SUCC 1.77 0.07 1.65 0.03
Data are presented as means  SE. Lean/obese n: pyruvate (P) plus
malate (M), 18/12; palmitoyl-DL-carnitine (PC) plus malate, 16/10;
pyruvate plus malate plus glutamate (G), 5/11; glutamate plus malate,
7/5; pyruvate plus malate plus glutamate plus succinate (Succ), 7/7.
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FIG. 1. In vitro oxidative capacity of isolated mitochondria. Mitochon-
drial fractions were rapidly isolated from basal vastus lateralis biop-
sies (, lean insulin-sensitive participants; f, obese insulin-resistant
participants). A: State 3 respiration rate was measured in response to
0.5 mmol/l ADP. B: State 4 respiration rate was measured following the
consumption of 0.5 mmol/l ADP. (See RESEARCH DESIGN AND METHODS for
concentrations.) Data are presented as means  SEM in units of nmol
min1 mg protein1. Lean/obese n: pyruvate (P) plus malate (M), 18/12;
palmitoyl-DL-carnitine (PC) plus malate, 16/10; pyruvate plus malate
plus glutamate (G), 5/11; glutamate plus malate, 7/5; pyruvate plus
malate plus glutamate plus succinate (Succ), 7/7.
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Fatty acid oxidation and amino acid metabolism.
Carnitine palmitoyltransferase 1B (CPT1B) was signifi-
cantly lower in the obese group. Methyl-malonate-semial-
dehyde dehydrogenase (ALDH6A1) and propionyl-CoA
carboxylase  were also lower in mitochondria from the
obese group. These proteins are involved in valine and
valine/isoleucine oxidation.
Fiber type and related proteins. MYH2, coding for
myosin type IIa, was higher in the obese versus lean
participants; MYH7 (myosin type I) was unchanged.
MYH1, coding for myosin type IIx, was higher in the obese
participants. In agreement with the myosin isoforms, the
Ca2 ATPase fast twitch isoform (ATP2A1) was signifi-
cantly higher and the slow twitch isoform (ATP2A2)
tended to be lower (P 	 0.07) in mitochondria from obese
individuals. CASQ2, the major calsequestrin isoform in
cardiac muscle, comprises 50% of the calsequestrin popu-
lation in slow oxidative muscle fibers. CASQ2 relative
abundance was lower in mitochondria from obese
individuals.
Comparison of protein abundance differences identi-
fied by mass spectrometry with immunoblot analysis.
Mitochondrial lysates were probed for COXIV abundance,
and no difference was observed between lean and obese
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FIG. 2. In vitro ROS production rates. A: Diagram indicating the
electron transport chain complexes along with their substrates
(NADH, FADH2, ubiquinone, or cytochrome c) and the inhibitors
that target them (red text: rotenone, antimycin A, myxothya-
zole, and oligomycin). Complexes I and III contain ROS-gener-
ating sites (red arrows). Black full arrows show the path of
electron flow within the inner mitochondrial membrane (IMM),
and black dashed arrows show the directional path of protons
across the IMM. Electrons can flow from complex II to I
(reverse electron flow) and produce ROS; rotenone blocks this
flow from complex II. ROS production by complex I is enhanced
in the presence of rotenone because rotenone’s binding site is
downstream of the ROS-producing site in this complex. B: ROS
production rates were quantified by incubating isolated mito-
chondria (10 g) with various substrate combinations, Amplex
Red, and horseradish peroxidase (see RESEARCH DESIGN AND METH-
ODS for detailed procedures). (, lean insulin-sensitive par-
ticipants; f, obese insulin-resistant participants.) Data are
presented as means  SEM; n  7 per substrate combination.
**P < 0.05 vs. lean participants. G, glutamate; M, malate; O, 1
g/ml oligomycin; P, pyruvate; PC, palmitoyl-DL-carnitine; R, 10
mol/l rotenone; Succ, succinate.
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groups (P 	 0.4), as predicted by the mass spectrometry
data (Fig. 4). ALDH6A1 abundance normalized to COXIV
(P 	 0.06) (ALDH6A1 abundance without normalization
to the COXIV loading control resulted in P	 0.04) showed
a 59% lower abundance in obesity by immunoblot—com-
parable with the 52% lower abundance determined by
mass spectrometry.
DISCUSSION
It has been proposed that excess lipid availability com-
bined with a lower muscular capacity to oxidize fat (24)
may lead to accumulation of intramyocellular lipids (25).
This in turn is thought to lead to insulin-signaling abnor-
malities and insulin resistance (1). Lower oxidative capac-
ity could be due to lower mitochondrial content, a defect
intrinsic to the individual mitochondrion, or both. Mito-
chondrial content was significantly lower in the obese
individuals, consistent with previous reports (2–5). To
determine the presence of intrinsic defects, mitochondria
were isolated from lean, insulin-sensitive and obese, insu-
lin-resistant human vastus lateralis muscle. The lower
mitochondrial content but similar VO2max values in the
obese versus lean volunteers may appear contradictory.
However, VO2max primarily reflects cardiovascular, rather
than mitochondrial, parameters (26,27).
With regard to intrinsic characteristics of the mitochon-
dria, we used the substrate combinations of pyruvate,
glutamate, and pyruvate plus glutamate (all including
malate), which rely on complex I activity, whereas the
addition of succinate recruits complex II activity. Fatty
acid oxidation requires complexes I and II and the electron
transfer flavoprotein shuttling electrons from dehydroge-
nases within the -oxidation pathway to the electron
transport chain (ETC). Basal and maximal respiration
rates, regardless of substrates, did not differ in the obese
participants—a result similar to that in a recent study (11).
These findings are in accordance with some (9,28) but not
all (8,10) studies assessing mitochondrial function in insu-
lin resistance and type 2 diabetes. Differences between the
present results and findings of decreased mitochondrial
function in diabetes could be due to the possibility that
insulin resistance itself is not associated with gross
changes in mitochondrial function or mitochondrial pro-
tein abundance; rather, mitochondrial dysfunction may be
more associated with hyperglycemia. Results of a whole
muscle proteomics comparison of lean and obese normo-
glycemic and type 2 diabetic individuals showed that
decreases in ETC components and other mitochondrial
proteins are most pronounced in the diabetics, with more
moderate changes in the obese group (22). In addition,
most of the earlier studies did not report aerobic fitness
measurements (8,9,28), whereas one study did match the
control and diabetic subjects for whole-body aerobic
power (VO2max) (10). The lean and obese individuals in the
present study had comparable VO2max and glycemia, and
their muscle mitochondria displayed similar maximal sub-
strate oxidation rates, coupling, and respiratory con-
trol—in contrast to the study of Phielix et al. (10). These
differences suggest that the progression from insulin resis-
tance to type 2 diabetes may result in functional defects in
SM mitochondria. On the other hand, our data suggest that
reports of decreased in vivo ATP turnover in resting
insulin-resistant muscle (6,7,29) most likely reflect de-
creased cellular ATP demand, given that 1) in vivo mito-
chondria rest at 2% of their oxidative potential (30), 2)
the differences in observed mitochondrial content were
rather small, and 3) insulin resistance appears to improve,
not degrade, the cellular energy state defended by muscle
mitochondria. If higher GATP had any influence on resting
ATP turnover, it would be predicted to be in the opposite
direction (31). Our results show that there are no intrinsic
defects in mitochondrial oxidative capacity in insulin
resistance without hyperglycemia. Taken together, these
data indicate that with regard to substrate oxidation, the
findings of decreased ATP turnover in vivo (6,7,29) likely
are explained on a gross level by a decrease in mitochon-
drial content in insulin-resistant muscle.
Nevertheless, there were more subtle intrinsic differ-
ences in the function of mitochondria from insulin-
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FIG. 3. Static head GATP. Isolated mitochondria were challenged with
pyruvate plus malate at different PCr-to-Cr ratios. A: schematic repre-
sentation of the JO2 vs. GATP plot. B: The static head GATP was
calculated by extrapolating the curve of the JO2 vs. GATP curve to
JO2  0. (, lean insulin-sensitive participants; f, obese insulin-
resistant participants.) Data are presented as means  SEM; n  7 per
group. Student’s t test was performed. *P < 0.01 vs. lean participants.
TABLE 3
Detected ETC subunits by tandem mass spectrometry
Complex
Number of known
subunits
Assigned
in 16
participants
Assigned
in 8
participants
I 46 27 34
II 4 2 2
III 9 5 6
IV 16 (plus SURF1 7 9
and SCO1)
V 19 (plus ATPAF1/2) 10 13
Number of electron transport chain subunits confidently assigned in
half or all subjects.
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resistant muscle. In resting muscle, mitochondrial
oxidative flux is extremely low (32), with very low
[ADP]f and robust (highly negative) GATP (31). Con-
tractile activity can elicit extremely high oxidative flux,
revealing a cellular aerobic scope spanning two orders
of magnitude (30). The metabolic signals that control
respiration over this range include both kinetic (e.g.,
[ADP] or KMADP) and thermodynamic (GATP) compo-
nents. The creatine kinase energy clamp provides an in
vitro evaluation of the mitochondrial sensitivity to these
signals. In the present study, the KMADP determined
using the creatine kinase clamp for respiration was not
different between groups. However, extrapolation of the
thermodynamic force-flow relation to the hypothetical
zero JO2 resulted in significantly more negative (higher)
static head GATP in mitochondria isolated from insulin-
resistant muscle. This finding is consistent with the obser-
vation of Petersen et al. (6), who used 31P–nuclear magnetic
resonance to show that the inorganic phosphate–to–
phosphocreatine ratio is lower in insulin-resistant than in
insulin-sensitive muscle. Lower inorganic phosphate and
more robust GATP are characteristics that differentiate
type II from type I mammalian muscle cells (33). It is
therefore noteworthy that insulin-resistant muscle showed
trends toward greater expression of type II myocyte
proteins, e.g., MYH2 (type IIa), MYH1 (type IIx), ATP2A1
(Ca2 ATPase fast twitch isoform), and higher PYGM
(glycogen phosphorylase).
Taken together, these data suggest that, at the low
metabolic turnover rates associated with rest, mito-
TABLE 4
Protein abundance differing significantly in isolated mitochondria from insulin-resistant skeletal muscle of obese subjects
Protein name (gene name)
Fold change in
mitochondria
from obese (log2)
P (Student’s
t test)
Lean/obese subjects
with protein
assigned (n)
Total spectra
per Group
Lean Obese
Myosin-2 (MYH2) 0.92 0.16 0.01 8/8 2,664 4,821
Myosin-1 (MYH1) 1.74 0.23 0.01 8/8 1,691 4,239
Methylmalonate-semialdehyde dehydrogenase
acylating, mitochondrial precursor (ALDH6A1) 1.05 0.12 0.01 7/5 64 22
Isoform SERCA1A/B of sarcoplasmic/endoplasmic
reticulum calcium ATPase 1 (ATP2A1) 0.75  0.15 0.01 8/8 2,433 3,748
Glycogen phosphorylase, muscle form (PYGM) 1.40 0.20 0.01 6/5 19 38
Peroxiredoxin-2 (PRDX2) 0.93 0.20 0.01 8/7 72 113
Prenylcysteine oxidase 1 precursor (PCYOX1) 1.07 0.18 0.01 4/6 11 32
Calsequestrin-2 precursor (CASQ2) 0.71 0.11 0.01 8/8 295 169
Dihydropyridine receptor 2 subunit (CACNA2D1) 1.17 0.32 0.02 7/7 47 102
Apolipoprotein A-I precursor (APOA1) 1.04 0.16 0.02 7/8 56 100
NADH dehydrogenase ubiquinone 1 subunit C2
(NDUFC2) 0.58 0.16 0.02 8/8 57 37
Carnitine O-palmitoyltransferase I, muscle isoform
(CPT1B) 0.81 0.32 0.03 8/7 114 62
NADH dehydrogenase ubiquinone 1 subcomplex
subunit 8 (NDUFA8) 0.30 0.12 0.03 8/8 1,487 1,152
NADH dehydrogenase ubiquinone 1 subcomplex
subunit 11 (NDUFA11) 0.50 0.16 0.04 8/8 259 176
Similar to CG7601-PA (DHRS7C) 0.63 0.14 0.04 8/7 64 82
Isoform 1 of tripartite motif-containing protein 72
(TRIM72) 0.85 0.37 0.04 8/6 32 15
Cytochrome c oxidase subunit 5B, mitochondrial
precursor (COX5B) 0.33 0.09 0.04 8/8 576 428
NADH dehydrogenase ubiquinone iron-sulfur protein
2 (NDUFS2) 0.20 0.05 0.05 8/8 426 349
Propionyl-CoA carboxylase  chain, mitochondrial
precursor (PCCB) 0.80 0.21 0.05 5/5 11 6
NADH dehydrogenase;NADH dehydrogenase
ubiquinone 1 subcomplex subunit 8 (NDUFB8) 0.31 0.13 0.05 8/8 244 188
Erythrocyte band 7 integral membrane protein (STOM) 1.24 0.42 0.05 6/8 24 78
Data are means  SE unless otherwise indicated. Total spectra 	 sum of spectra across participants within the group.
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FIG. 4. Comparison of protein abundances determined by mass spectrom-
etry to immunoblotting. Mitochondrial lysates (20 g) (n  3–4) were
probed for ALDH6A1 and COXIV abundances. ALDH6A1 abundance was
normalized to a loading control (COXIV). (, lean insulin-sensitive
participants; f, obese insulin-resistant participants.) *P  0.06.
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chondria from insulin-resistant muscle maintain higher
thermodynamic driving forces. Because the protonmo-
tive force and the oxidation-reduction energy (redox
pressure) down the electron transport chain are the
energetic precursors to GATP, higher ROS production
rates by mitochondria from the obese group would be
the predicted outcome. This result was experimentally
observed. In the absence of rotenone (Fig. 2A), ROS
production was higher in the obese individuals, suggest-
ing that muscle mitochondria from obese individuals
produce more ROS at complex I and/or complex III.
Complex III has been labeled as a higher contributor of
ROS in SM mitochondria (14). Secondly, the level of
long-chain fatty acid oxidation intermediates within the
matrix, which have been postulated to be elevated in
insulin resistance due to incomplete -oxidation (34),
dictates the amount of ROS produced (35) specifically at
the level of complex III and the electron transfer
flavoprotein (35). Higher rates of ROS production in
insulin resistance have been reported previously (16)
and precede the onset of the diabetic state in mice on a
high-fat diet (36). Lower rates of ROS production in
obese individuals, but not type 2 diabetic individuals,
have been reported (37). However, this study did not
report maximal ROS production rates because mito-
chondria were not incubated with oligomycin during the
measurements. On the other hand, the insulin-sensitiz-
ing effect of exercise training is abrogated upon con-
sumption of antioxidants, supporting a positive role for
ROS in the modulation of insulin sensitivity (38). Addi-
tionally, mice lacking glutathione peroxidase are pro-
tected from insulin resistance induced by high-fat diets
(39). Therefore, it is possible that higher ROS produc-
tion rates observed in isolated mitochondria from obese
individuals may be a compensatory mechanism to in-
crease insulin action; this possibility warrants further
investigation because ROS have also been identified as a
causal factor of insulin resistance (12).
In order to guide future research efforts studying the
role of the mitochondrion in insulin resistance, we per-
formed an analysis of the abundance of individual proteins
in mitochondria (22,40). We used equal amounts of iso-
lated mitochondrial protein for proteomic analysis, result-
ing in a comparison of relative protein abundance per
mitochondrial mass. Several individual subunits of ETC
complex I were significantly reduced in obese, insulin-
resistant individuals. Complex I is a 980 kDa conglomerate
comprised of 46 subunits in mammals (41). Fourteen of
these 46 subunits are the core subunits, responsible for the
location of the redox centers (flavin mononucleotide and
eight Fe-S cluters) (41). The remaining 32 subunits are less
well characterized: they may be involved in maintaining
the structure of the complex, in linkage of the complex to
the inner mitochondrial membrane, or even in altering
ROS generation (41). Five complex I subunits were signif-
icantly lower in the obese individuals. These subunits
were distributed among the four subcomplexes of com-
plex I (NDUFB3/B8/C2 in subcomplex I, ND1 in I,
NDUFA8/A11/S5 in I, and NDUFS2 in I) (41). A negative
correlation has previously been found between the degree
of insulin resistance and complex I activity (4). NDUFS2
and ND1 are two subunits found within the core of
complex I. A lower abundance of these two subunits did
not translate to a detectable decrease in NADH-linked
respiration.
The present study also shows a lower abundance of the
muscle outer-mitochondrial membrane carnitine palmi-
toyltransferase 1B (CPT1B). Cpt1B transesterifies long-
chain fatty acyl-CoAs to fatty acylcarnitines, which are
transported into the mitochondrial matrix for -oxidation
(42). Its expression is dependent on peroxisome prolifera-
tor–activated receptor coactivator-1 (PGC-1) (43) tran-
scription factor activity. Reduced Cpt1B protein level
could be a direct consequence of lower PGC-1 gene
expression reported in insulin-resistant muscle (44,45).
Furthermore, increasing Cpt1B protein levels in SM in-
creased fatty acid oxidation and lowered the severity of
insulin resistance in rats on a high-fat diet (46). In the
present study, the utilization of PC in the assessment of
fatty acid–mediated mitochondrial respiration bypassed
the highly regulated CPT system. Our results therefore
show that -oxidation activity per se is not impaired in
insulin-resistant muscle but, rather, that the protein deter-
mining the rate of fatty acid entry into mitrochondria,
Cpt1B, was decreased.
The last set of proteins altered in the proteomics anal-
ysis involved enzymes involved in BCAA catabolism. MMS
dehydrogenase and propionyl-CoA carboxylase are re-
quired for valine and isoleucine metabolism before entry
into the tricarboxylic acid (TCA) cycle as succinyl-CoA.
Decreased BCAA oxidation, together with increased pro-
teolysis in insulin resistance (47), could lead to increased
intracellular BCAA concentrations. Such an increase could
activate mammalian target of rapamycin signaling, which
can inhibit insulin signaling and produce insulin resistance
(48). Moreover, recent metabolomic studies in humans
and BCAA/high-fat feeding studies in rodents indicate that
alterations in BCAA metabolism are associated with insu-
lin resistance (49,50). Alternatively, or in addition, it is
possible that decreased entry of BCAA into the TCA cycle
could reduce TCA cycle flux and lead to accumulation of
incompletely oxidized fatty acids, as suggested by Koves
and Muoio (34). A decreased CPT1B abundance then
could be a compensatory effort to protect the cell from
accumulation of incompletely oxidized fatty acids and
other fatty acid metabolites. A caveat is that this scenario
would imply a rate-determining role of BCAA-derived TCA
intermediates.
In conclusion, mitochondria isolated from skeletal mus-
cle from obese and overweight insulin-resistant volunteers
do not have an intrinsic abnormality in fuel oxidation.
However, measurements of citrate synthase activity and
mitochondrial protein indicated a decrease in mitochon-
drial mass. Therefore, in order to maintain similar respi-
ration rates, we propose that mitochondria in insulin-
resistant muscle undergo adaptations that allow them to
generate a more negative GATP. A consequence of this
higher GATP would be increased ROS production rates at
rest (51) as found here. We propose a model for these data
shown in Fig. 5.
We also defined new abnormalities in mitochondria
from human insulin-resistant muscle using mass spectrom-
etry. A number of complex I subunits were found to be
lower in mitochondria from insulin-resistant muscle, but
the lack of characterization of function of most complex I
subunits makes it difficult to interpret the consequences of
this finding. However, these differences may be related to
differences in ROS production. Mitochondria from insulin-
resistant muscle also was found to contain less carnitine
palmitoyltransferase 1, offering an explanation for the
intramuscular lipid accumulation observed in insulin-resis-
tant muscle (25). In addition, enzymes involved in BCAA
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metabolism were lower in abundance in insulin-resistant
muscle. In addition to the lower mitochondrial content in
insulin-resistant muscle, perturbations intrinsic to mito-
chondria could alter ROS production, limit the entry of
fatty acids into the matrix and affect the overall oxidation
rate of BCAA.
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